Small ruminant farming is a traditional activity deeply rooted in the agricultural societies of North African countries. Indeed, this activity continues to represent one of the essential, if not exclusive, sources of income for a significant portion of the agricultural populations in these regions. In Tunisia, the small ruminant population consists of four sheep breeds and one goat breed. Sheep farming accounts for 39% of total red meat production (OEP, 2014) with more than 6.8 million head, including approximately 3.9 million ewes (ONAGRI, 2012) belonging to four different breeds: Barbarine (60.3%), Queue fine de l’Ouest (34.6%), Noir de Thibar (2.1%) and Sicilo Sarde (0.7%).
The Barbarine breed, known locally as “Nejdi” or “fat-tailed sheep,” is the most widespread in Tunisia and is mainly used for meat production in extensive farming systems (Djemali et al., 1994). The second breed is the “Queue fine de l’Ouest” breed, also known as “Bergui,” which is mainly found in the steppes of central Tunisia. The Black Thibar breed is a composite black-wool sheep found in the sub-humid region of northern Tunisia and used for meat production. Finally, the Sicilo Sarde breed is the only dairy sheep breed in North Africa. It is the result of a cross between two imported Italian dairy breeds (Sarde and Sicilienne) from Sicily and is currently limited to areas in northwestern Tunisia (Djemali, 2000).
The Tunisian goat population numbers around 1.5 million, including 900,000 breeding females. The majority of goats are found in the southern regions of Tunisia. Around 95% of this population is made up of a native black-coated breed known as the “Arbi” breed.
Diseases have a negative impact on animal production and welfare. The costs they generate are estimated at 17% of total animal production income in developed countries and between 30% and 50% in developing countries. However, to date, there are few breeding programs for disease resistance in place that have yielded conclusive results.
Diseases caused by parasites, bacteria, or viruses have always been a major obstacle to efficient sheep and goat production worldwide. Controlling or eliminating infectious agents in farm animals has always depended on the use of vaccines, drugs, and/or the elimination of sick animals. However, these measures have failed to eradicate some of the major infectious diseases in livestock. Indeed, prolonged use of antibiotics, vaccines, or other treatments often leads to the development of resistant strains of pathogens or parasites. This significantly reduces the effectiveness of treatments. The use of genetic improvement through research into disease defense mechanisms will provide new approaches to combating diseases affecting livestock. Differential genetic resistance to disease in livestock has been known for a long time (Hutt, 1958). The discovery of immune response genes has provided new impetus for studying the genetic control of the immune response in livestock. However, genetic selection methods for disease resistance in small ruminants have not been widely used, as selection for meat production traits has ignored the improvement of disease resistance traits. Furthermore, due to the complexity of infectious diseases caused by multiple pathogens, selection becomes ineffective in controlling all types of diseases. Finally, basic research has not identified enough genes that can be used in selection for pathogen resistance.
As part of this project, we looked at various genes involved in the immune response. Two main categories of immune responses can be distinguished: innate immunity and adaptive immunity (Medzhitov, 2007). Among the molecules involved in immunity, those of the major histocompatibility complex (MHC) play an essential role in the activation of adaptive immune responses, while Toll-like receptors (TLRs) are involved in innate immunity mechanisms by recognizing molecular motifs conserved in many pathogens. On the other hand, cytokines are important mediators of the immune system involved in intercellular communication and responsible for initiating, amplifying, and regulating inflammation in response to a pathogen challenge. They perform several roles associated with their functions as mediators of innate and adaptive immune responses (Downing et al., 2010).
A review of the most recent knowledge on these gene groups in different livestock models confirms their central role in controlling immune mechanisms. Functional studies have revealed numerous associations between these genes and various physiological traits, including both the quality of the immune response to various pathogens and zootechnical performance in terms of production and reproduction (Maillard, 1998). Several studies have been conducted, mainly in sheep, with the aim of identifying significant associations between MHC gene polymorphism and resistance to nematodes, bacteria, and viruses (Shen et al., 2014). However, a significant association has only been observed between DRB1 and DQB1 gene polymorphism and resistance to cystic echinococcosis (Shen et al., 2014). In addition, certain MHC alleles have been associated with resistance to bovine leukemia virus (Gutierrez et al., 2016).
On the other hand, analysis of TLR genes in several livestock species has shown a significant association between their polymorphism and resistance to certain pathogens. Indeed, TLR2 has been associated with susceptibility/resistance to tuberculosis in cattle and has been suggested as a selection target in breeding programs. Polymorphism in the TLR4 and TLR5 genes has been associated with resistance to brucellosis and Mycobacterium avium, respectively (Bhaladhare et al., 2016).
Finally, polymorphism in certain cytokine genes (GM-CSF, IL-4, IL-8, IL-12a, and IL-13) has been associated with resistance/susceptibility to various diseases (Downing et al., 2010).
There are several reasons for using selection rather than traditional methods to control diseases. Selection for disease resistance could improve the economic performance of herds by both reducing the subclinical effect of diseases on production and decreasing the number and severity of clinical cases.